Results 191 to 200 of about 3,660,119 (305)

Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial-mesenchymal transition. [PDF]

Nat Prod Bioprospect
Zhong Y, Xiao C, Liang Y, Wang P, Long Y, Li S, Song N, Shang W, Yang W, Zhang X.   +9 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Ciência e destruição Science and destruction

Estudos Avançados, 2010
Carlos Malferrari
doaj   +1 more source

Correction: Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomes. [PDF]

Front Med (Lausanne)
Diehl K, Stoos E, Becker A, Orfaly VE, Nelson J, Gillespie J, Ng J, Tobey T, Latour E, Ludzik J, Berry EG, Geller AC, Jacobe H, Leitenberger J, McClanahan D, Tran J, Prasad S, Mengden-Koon S, Nelson KC, Petering R, Verdieck A, Savory S, Smith EH, Tofte S, Weinstock MA, White K, Wisco O, Curiel-Lewandrowski C, Swetter SM, Witkowski AM, Ferris L, Black S, Xu R, Xu S, Leachman S.   +34 more
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Author Correction: Octadecanoids as emerging lipid mediators in cnidarian-dinoflagellate symbiosis. [PDF]

Commun Biol
Botana MT, Lewis RE, Quaranta A, Salamin O, Revol-Cavalier J, Oakley CA, Feussner I, Hamberg M, Grossman AR, Suggett DJ, Weis VM, Wheelock CE, Davy SK.   +12 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Optimized T-shaped resonator via local enhancement model integration within a cell for enhanced Rydberg-atom receiver sensing. [PDF]

Commun Eng
Wu B, Sun Z, Sang D, Liu Y, An Q, Lin Y, Fu Y.   +6 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source